Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NR4A3 modulators(nuclear receptor subfamily 4 group A member 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lewy Body Disease | Discovery | US | 29 Jan 2024 | |
Parkinson Disease | Discovery | US | 29 Jan 2024 |